Bausch Health Companies Inc (BHC) Stock Price, Quote & News

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. T...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 514 744 6792

Website: www.bauschhealth.com

Address:

2150 St. Elzéar Blvd. West, Laval, Canada

Stock_Spectator Aug. 25 at 2:56 PM

$BLCO $BHC Thomas J. Appio is the Chairman of the Board of Bausch + Lomb Corporation (NYSE: BLCO).He assumed the role on August 10, 2026, succeeding Brent Saunders, who continues to serve as a member of the board while remaining the company's Chief Executive Officer. Appio is also the CEO of Bausch Health Companies Inc.

0 · Reply

brunoq14 Aug. 24 at 6:41 PM

$BHC https://clinicaltrials.gov/study/NCT07428538. Update for the Larsucosterol trial 08/24/2028 Now 86 locations, 21 currently recruiting.

2 · Reply

FU2 Aug. 24 at 2:28 PM

$BHC heading to $8

1 · Reply

FU2 Aug. 23 at 11:58 PM

$BHC 5 years later and BHC is still an options bitch. Good luck longs. If we can get back to $5.95 just load the boat.

0 · Reply

truckersam Aug. 22 at 9:16 PM

$BHC hopefully sooner than later

0 · Reply

stutz7 Aug. 22 at 9:08 PM

$BHC

1 · Reply

AnthonyNicholas Aug. 21 at 6:36 PM

$BHC what did I miss? What happened? Why are we drop $.30?

1 · Reply

gary918 Aug. 21 at 6:34 PM

$BHC I thought this would happen today. There were over 8,000 call contracts in the money. BHC is relatively thinly traded so the market maker needs to keep delta neutral. Other traders also know this so they will also short. It sucks but the offset is when the contracts were entered into the MM had to buy. We might get a bounce Monday. Always something with this stock.

0 · Reply

FU2 Aug. 21 at 3:55 PM

$BHC im surprised we aren't at $6.50 flat.

0 · Reply

Coolhat1 Aug. 21 at 1:04 PM

$BHC this is actually massive how is no one seeing this something is definitely happening also holding gains very well🤔🤔

1 · Reply

Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results

Aug 17, 2026, 8:00 AM EDT - 9 days ago

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners

2026-08-16T12:49:43.000Z - 10 days ago

Bausch Health put volume heavy and directionally bearish

Aug 6, 2026, 7:04 AM EDT - 20 days ago

Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board

BLCO

Jul 29, 2026, 5:00 PM EDT - 27 days ago

Bausch Health Companies Earnings Call Transcript: Q2 2026

Jul 29, 2026, 5:00 PM EDT - 27 days ago

Bausch Health Companies Earnings release: Q2 2026

Jul 29, 2026, 5:00 PM EDT - 27 days ago

Bausch Health Companies Slides: Q2 2026

Jul 29, 2026, 5:00 PM EDT - 27 days ago

Bausch Health Companies Quarterly report: Q2 2026

2026-07-29T20:18:16.000Z - 27 days ago

Bausch Health reports Q2 non-GAAP EPS $1.26, consensus $1.01

Jul 29, 2026, 4:05 PM EDT - 27 days ago

BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE

Jul 9, 2026, 5:12 PM EDT - 6 weeks ago

Bausch to stop glaucoma eye drop development after trial miss

Jul 7, 2026, 7:00 AM EDT - 7 weeks ago

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026

Jul 1, 2026, 4:15 PM EDT - 7 weeks ago

Michael Goettler Resigns from Bausch Health's Board of Directors

May 28, 2026, 4:15 PM EDT - 3 months ago

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China

May 20, 2026, 9:30 AM EDT - 3 months ago

Bausch Health Companies Transcript: RBC Capital Markets Global Healthcare Conference 2026

May 19, 2026, 4:15 PM EDT - 3 months ago

Bausch Health Announces 2026 Annual Meeting of Shareholder Results

May 19, 2026, 10:25 AM EDT - 3 months ago

Bausch Health Companies Transcript: Barclays 30th Annual Leveraged Finance Conference 2026

May 19, 2026, 9:00 AM EDT - 3 months ago

Bausch Health Companies Transcript: AGM 2026

May 19, 2026, 7:00 AM EDT - 3 months ago

Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States

May 13, 2026, 7:00 AM EDT - 3 months ago

Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference

May 12, 2026, 4:15 PM EDT - 3 months ago

Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference

May 7, 2026, 7:00 AM EDT - 3 months ago

Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe

Apr 29, 2026, 5:00 PM EDT - 4 months ago

Bausch Health Companies Earnings Call Transcript: Q1 2026

Apr 29, 2026, 5:00 PM EDT - 4 months ago

Bausch Health Companies Slides: Q1 2026

Apr 29, 2026, 5:00 PM EDT - 4 months ago

Bausch Health Companies Earnings release: Q1 2026

Apr 29, 2026, 5:00 PM EDT - 4 months ago

Bausch Health Companies Quarterly report: Q1 2026

2026-04-29T20:33:36.000Z - 4 months ago

Bausch Health reports Q1 non-GAAP EPS 78c, consensus 69c

2026-04-29T20:29:28.000Z - 4 months ago

Bausch Health sees 2026 revenue $10.67B-$10.92B, consensus $10.68B

Apr 29, 2026, 4:05 PM EDT - 4 months ago

BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS

Apr 23, 2026, 7:00 AM EDT - 4 months ago

Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration

Apr 14, 2026, 8:00 AM EDT - 4 months ago

Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering

Apr 8, 2026, 8:00 AM EDT - 5 months ago

Bausch Health Companies Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 5 months ago

Bausch Health Companies Proxy statement: Proxy filing

Apr 8, 2026, 7:00 AM EDT - 5 months ago

Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update

Apr 7, 2026, 7:00 AM EDT - 5 months ago

Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe

Mar 31, 2026, 7:00 AM EDT - 5 months ago

Bausch Health to Announce First Quarter 2026 Results on April 29, 2026

Mar 26, 2026, 8:00 AM EDT - 5 months ago

Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program

2026-02-25T10:15:55.000Z - 6 months ago

Bausch Health price target lowered to $7 from $8 at Barclays

Feb 23, 2026, 8:00 AM EST - 6 months ago

Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada

Feb 19, 2026, 8:00 AM EST - 6 months ago

Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres

Feb 18, 2026, 5:00 PM EST - 6 months ago

Bausch Health Companies Earnings Call Transcript: Q4 2025

Feb 18, 2026, 5:00 PM EST - 6 months ago

Bausch Health Companies Annual report: Q4 2025

Feb 18, 2026, 5:00 PM EST - 6 months ago

Bausch Health Companies Earnings release: Q4 2025

Feb 18, 2026, 5:00 PM EST - 6 months ago

Bausch Health Companies Slides: Q4 2025

2026-02-18T21:21:45.000Z - 6 months ago

Bausch Health reports Q4 EPS (30c) vs. 25c a year ago

Feb 18, 2026, 4:05 PM EST - 6 months ago

BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

Feb 17, 2026, 7:00 AM EST - 6 months ago

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Feb 11, 2026, 8:00 AM EST - 7 months ago

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program

2026-02-02T19:40:25.000Z - 7 months ago

NY AG announces settlement with Lannett and Bausch Health

2026-01-23T18:55:29.000Z - 7 months ago

Bausch’s RED-C miss raises pressure ahead of Xifaxan LOE, Truist says

Jan 23, 2026, 7:52 AM EST - 7 months ago

Bausch Health's brain dysfunction treatment fails late-stage trial

2026-01-23T12:50:15.000Z - 7 months ago

Bausch Health results from Phase 3 RED-C program did not meet primary endpoint

Jan 23, 2026, 7:45 AM EST - 7 months ago

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

Jan 21, 2026, 7:00 AM EST - 7 months ago

Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026

Jan 14, 2026, 6:45 PM EST - 7 months ago

Bausch Health Companies Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 7 months ago

Bausch Health Companies Slides: 44th Annual J.P. Morgan Healthcare Conference

2026-01-07T12:20:14.000Z - 8 months ago

Bausch Health price target raised to $8 from $7 at Truist

Jan 5, 2026, 7:00 AM EST - 8 months ago

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 23, 2025, 5:35 PM EST - 8 months ago

Bausch Health Announces Final Results and Expiration of Exchange Offers

Dec 8, 2025, 7:22 PM EST - 9 months ago

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

Dec 2, 2025, 10:50 AM EST - 9 months ago

Bausch Health Companies Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 1, 2025, 7:00 AM EST - 9 months ago

Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China

Nov 24, 2025, 7:05 AM EST - 9 months ago

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

Nov 18, 2025, 7:00 AM EST - 10 months ago

Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference

Nov 13, 2025, 8:18 AM EST - 10 months ago

Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical

Nov 13, 2025, 7:00 AM EST - 10 months ago

Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day

Nov 5, 2025, 8:00 AM EST - 10 months ago

Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Nov 3, 2025, 4:30 PM EST - 10 months ago

Bausch + Lomb to Hold Investor Day on Nov. 13

Oct 29, 2025, 5:00 PM EDT - 10 months ago

Bausch Health Companies Earnings Call Transcript: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 10 months ago

Bausch Health Companies Quarterly report: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 10 months ago

Bausch Health Companies Earnings release: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 10 months ago

Bausch Health Companies Slides: Q3 2025

Oct 29, 2025, 4:05 PM EDT - 10 months ago

Bausch Health Announces Third Quarter 2025 Results

Oct 9, 2025, 7:00 AM EDT - 11 months ago

Bausch Health Announces Results of Special Meeting of Shareholders

Sep 30, 2025, 8:00 AM EDT - 11 months ago

Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV

Sep 30, 2025, 7:00 AM EDT - 11 months ago

Bausch Health to Announce Third Quarter 2025 Results on October 29

Sep 29, 2025, 8:00 AM EDT - 11 months ago

Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

Sep 11, 2025, 8:35 AM EDT - 1 year ago

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

Sep 11, 2025, 7:00 AM EDT - 1 year ago

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

Sep 9, 2025, 7:00 AM EDT - 1 year ago

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

Sep 5, 2025, 8:02 AM EDT - 1 year ago

Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System

Aug 27, 2025, 8:00 AM EDT - 1 year ago

Bausch Health Companies Proxy statement: Proxy Filing

Aug 26, 2025, 8:00 AM EDT - 1 year ago

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

DRRX

Aug 21, 2025, 8:02 AM EDT - 1 year ago

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan

Aug 18, 2025, 5:48 PM EDT - 1 year ago

Bausch + Lomb board members resign after Icahn agreement ends

Stock_Spectator Aug. 25 at 2:56 PM

0 · Reply

brunoq14 Aug. 24 at 6:41 PM

$BHC https://clinicaltrials.gov/study/NCT07428538. Update for the Larsucosterol trial 08/24/2028 Now 86 locations, 21 currently recruiting.

2 · Reply

FU2 Aug. 24 at 2:28 PM

$BHC heading to $8

1 · Reply

FU2 Aug. 23 at 11:58 PM

$BHC 5 years later and BHC is still an options bitch. Good luck longs. If we can get back to $5.95 just load the boat.

0 · Reply

truckersam Aug. 22 at 9:16 PM

$BHC hopefully sooner than later

0 · Reply

stutz7 Aug. 22 at 9:08 PM

$BHC

1 · Reply

AnthonyNicholas Aug. 21 at 6:36 PM

$BHC what did I miss? What happened? Why are we drop $.30?

1 · Reply

gary918 Aug. 21 at 6:34 PM

0 · Reply

FU2 Aug. 21 at 3:55 PM

$BHC im surprised we aren't at $6.50 flat.

0 · Reply

Coolhat1 Aug. 21 at 1:04 PM

$BHC this is actually massive how is no one seeing this something is definitely happening also holding gains very well🤔🤔

1 · Reply

Yrwegoing Aug. 21 at 10:05 AM

$BHC One week old but not a ton of press on Appio taking over as Chairman

2 · Reply

truckersam Aug. 20 at 5:43 PM

$BHC Dan how high is it going to go???

1 · Reply

Contrarian_Dan Aug. 19 at 5:43 PM

$BHC I would rather die than sell a single share of BHC at this price.

4 · Reply

algomezus Aug. 19 at 2:58 PM

$BHC Never get excited with Bausch. That is the number one rule.

0 · Reply

btradingwarehouse Aug. 19 at 2:43 PM

$BHC ...2BULLS... ... Champs !!! Just watch @blconnell That will give you sense of state of intentions of Mr. P and Co. ... All perfect !!! ... As always: Do NOT buy !!! (unless you are trader) Think of buying ~ >$10-12 ... Relax Smile Go ride your bicycle We perfect

0 · Reply

Coolhat1 Aug. 19 at 1:47 PM

$BHC $BLCO both moving higher and the new board at blco seems really promising

0 · Reply

AKTN Aug. 18 at 6:46 PM

$BHC DROP THE SCHOLARSHIP NEWS *unce unce unce unce unce*

0 · Reply

Mo_Better Aug. 18 at 3:34 PM

$BHC glad I bottom-fished this one…

0 · Reply

Bullchart Aug. 18 at 3:15 PM

$BHC break that Aug 3. 7.00 and heading for 10 resistance again

1 · Reply

Coolhat1 Aug. 18 at 2:24 PM

$BLCO $BHC wow what’s happens both rising

2 · Reply

Bullchart Aug. 17 at 5:31 PM

$BHC 5 to 10 consolidation on the bottom too long. This will prove worth holding with some new faces in charge.

0 · Reply

Coolhat1 Aug. 17 at 12:01 PM

$BHC 20 incoming scholarship just dropped

0 · Reply

Market Cap	2.50B
Revenue (ttm)	10.27B
Net Income (ttm)	157.00M
EPS (ttm)	N/A
PE Ratio	1.50
Forward PE	1.48
Profit Margin	1.53%
Debt to Equity Ratio	-25.86

Volume	3,455,700
Avg Vol	3,861,340
Day's Range	N/A - N/A
Shares Out	374.13M
Stochastic %K	61%
Beta	0.38
Analysts	Hold
Price Target	$6.92